comparemela.com

Latest Breaking News On - Hardware platform solutions - Page 5 : comparemela.com

Celestica Announces First Quarter 2021 Financial Results

Celestica Announces First Quarter 2021 Financial Results Celestica Inc., a leader in design, manufacturing and supply chain solutions for the world s most innovative companies, has announced financial results for the quarter ended March 31, 2021 (Q1 2021). “We had a strong start to the year as we delivered solid results for the quarter. Our revenue, non-IFRS adjusted EPS and non-IFRS operating margin were all above the midpoint of our guidance ranges for Q1 2021. In addition, we were able to further reduce our debt, while also returning capital to shareholders through our share buyback program,” said Rob Mionis, President and CEO, Celestica. “We are pleased with our operating performance despite the continuing challenges from the COVID-19 pandemic. We are excited by the opportunities in front of us and continue to focus on executing for our customers while driving profitable growth.”

Celestica Announces Fourth Quarter 2020 Financial Results

$0.22 to $0.28 (1) IFRS EPS of $0.16 for Q4 2020 included an aggregate charge of $0.13 (pre-tax) per share for employee stock-based compensation (SBC) expense, amortization of intangible assets (excluding computer software), restructuring charges, and de minimis Internal Relocation Costs (defined in Schedule 1 hereto). See the tables in Schedule 1 and note 10 to our December 31, 2020 unaudited interim condensed consolidated financial statements (Q4 2020 Interim Financial Statements) for per-item charges. This aggregate charge is towards the low end of our Q4 2020 guidance range of between $0.12 and $0.18 per share for these items, primarily due to lower than-expected restructuring charges. IFRS EPS for Q4 2020 included a $0.05 per share negative impact attributable to restructuring charges and a $0.06 per share negative impact attributable to estimated $8 million in COVID-19 Costs, offset in large part by a $0.08 per share positive impact attributable to COVID Recoveries (approxi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.